Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021

BJU Int. 2022 Feb;129(2):168-170. doi: 10.1111/bju.15629. Epub 2021 Nov 16.
No abstract available

MeSH terms

  • Drug Approval
  • Humans
  • United States
  • United States Food and Drug Administration
  • Urogenital Neoplasms*
  • Urologic Neoplasms* / drug therapy